From Science to Commercial Impact: Insights from Jumar’s BioAccelerate Program
A breakthrough discovery is only the beginning.
For biotech founders, the journey that follows involves transforming scientific potential into a company — defining a commercial pathway, building investor confidence and making decisions that shape the future of their venture.
Jumar Bioincubator’s BioAccelerate program is designed to support early-stage biotech companies through this critical stage of growth. The nine-month bespoke commercialisation coaching program connects biotech founders with experienced mentors who provide tailored guidance, strategic insights and ongoing support as companies move towards commercial readiness.
Helping biotech founders translate science into business
For Julie Sharp, Co-Founder and CEO at PremieHealth, the BioAccelerate program helped bridge the gap between scientific expertise and building a commercial biotech company. With a background in science, Julie used the program to refine PremieHealth’s commercialisation strategy, clarify business priorities and better understand the steps required to translate their research into a scalable venture.
Guidance from coach Nicholette Conway (Senior Researcher: Medical Technology and Pharmaceuticals at the University of Sydney) provided valuable perspective from someone who has experienced the commercialisation journey. The ongoing nature of the program — with regular sessions over nine months — allowed Julie to continuously refine her strategy, work through challenges and build confidence as the business evolved.
Building investor readiness and preparing for growth
For Henri Currie, COO at Gallant Bio, the value of BioAccelerate was in gaining an external perspective and having a trusted sounding board as the company prepared for its next stage of growth.
Through guidance from coach Tamara Mills, who leads leading venture investments for Edale Capital, Henri explored investor engagement strategies, gained insights into what investors are looking for, and refined how Gallant Bio communicates its value proposition.
Having a space to openly discuss challenges, ask questions and test ideas with someone who has already navigated the biotech journey provided valuable perspective. Access to Tamara’s experience and networks helped Gallant Bio think strategically about its future direction and position the company for future opportunities.
The value of long-term mentorship
From the coaching perspective, Tina Soulis, Founder and Director of Alithia Life Sciences, highlighted the value of building a deep, sustained understanding of each founder and their business. Rather than a one-off interaction, the nine-month structure allows coaches to engage closely with ventures over time — developing insight into the science, strategy and decisions shaping the company, and supporting founders through key moments as they evolve.BioAccelerate is built around the understanding that every biotech venture has a different path to commercialisation. The program provides founders with the time, structure and accountability to make meaningful progress on the strategic challenges that matter most to their company.
With an expert-matched coach by their side, founders can work through areas such as sharpening regulatory strategy and clinical evidence plans, building investor-ready commercial strategies and pitch positioning, clarifying core use cases and competitive positioning, and strengthening partnership and go-to-market strategies.
BioAccelerate is an exclusive program available to Jumar residents, providing early-stage biotech ventures with access to tailored commercialisation coaching as part of the broader support ecosystem at Jumar Bioincubator. Alongside access to purpose-built laboratory and office facilities, residents benefit from programs, networks and mentorship designed to help them navigate the challenges of building and scaling a biotech company.
.jpg)
.png)